PMID- 26166660 OWN - NLM STAT- MEDLINE DCOM- 20160212 LR - 20211203 IS - 2284-0729 (Electronic) IS - 1128-3602 (Linking) VI - 19 IP - 12 DP - 2015 Jun TI - Apigenin inhibits indoxyl sulfate-induced endoplasmic reticulum stress and anti-proliferative pathways, CHOP and IL-6/p21, in human renal proximal tubular cells. PG - 2303-10 LID - 9106 [pii] AB - OBJECTIVE: Indoxyl sulfate (IS) has been reported to induce endoplasmic reticulum (ER) stress in tubular cells and to inhibit the cell proliferation via ER stress and ERK/IL-6/p21 pathways. This study has investigated the effect of apigenin on IS-induced ER stress in immortalized human renal proximal tubular HK-2 cells. MATERIALS AND METHODS: Human Kidney 2 (HK-2) cells were treated with IS (5 mM) in the absence or presence of apigenin (10 muM) or salubrinal (20 muM) for indicated times under the serum-free condition. Cell viability was evaluated by MTT assay. The levels of protein expression and phosphorylation were evaluated by Western blot analysis. RESULTS: In HK-2 cells, apigenin completely inhibited IS-induced ER stress, as indicated by decreased expression of CHOP, ATF4 and GRP78, although the phosphorylated level of eIF2alpha did not decrease. IS-induced expression levels of IL-6 and p21 proteins were also inhibited by apigenin, with no significant changes in ERK activation. The suppression of cell proliferation by IS was abolished by salubrinal, an ER stress inhibitor, but not by apigenin. Apigenin inhibited the phosphorylation of Akt and GSK-3beta in IS-treated HK-2 cells. The phosphorylation of GSK-3beta, which was inhibited by apigenin, resulted in hypo-phosphorylation of retinoblastoma (Rb) protein, which was associated with the decrease in cyclin D1 expression. CONCLUSIONS: These results suggest that apigenin may inhibit IS-induced ER stress and expression of IL-6 and p21 proteins in HK-2 cells. It is most likely that apigenin, together with its inhibitory effect on ER stress, may also suppress the cell growth by inducing the loss of Rb phosphorylation, which was associated with the decrease in cyclin D1 expression by GSK-3beta activation through the inhibition of PI3K/Akt pathway. FAU - Jeon, B-J AU - Jeon BJ AD - Department of Pathology, College of Korean Medicine, Wonkwang University, Iksan, Jeonbuk, Republic of Korea. omdjbh@wku.ac.kr. FAU - Yang, H-M AU - Yang HM FAU - Lyu, Y-S AU - Lyu YS FAU - Pae, H-O AU - Pae HO FAU - Ju, S-M AU - Ju SM FAU - Jeon, B-H AU - Jeon BH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Italy TA - Eur Rev Med Pharmacol Sci JT - European review for medical and pharmacological sciences JID - 9717360 RN - 0 (CDKN1A protein, human) RN - 0 (Cyclin-Dependent Kinase Inhibitor p21) RN - 0 (DDIT3 protein, human) RN - 0 (Endoplasmic Reticulum Chaperone BiP) RN - 0 (HSPA5 protein, human) RN - 0 (IL6 protein, human) RN - 0 (Interleukin-6) RN - 147336-12-7 (Transcription Factor CHOP) RN - 7V515PI7F6 (Apigenin) RN - N187WK1Y1J (Indican) SB - IM MH - Apigenin/*pharmacology MH - Cell Cycle/drug effects/physiology MH - Cell Line, Transformed MH - Cell Proliferation/drug effects/physiology MH - Cyclin-Dependent Kinase Inhibitor p21/antagonists & inhibitors/*biosynthesis MH - Endoplasmic Reticulum Chaperone BiP MH - Endoplasmic Reticulum Stress/drug effects/*physiology MH - Humans MH - Indican/antagonists & inhibitors/*toxicity MH - Interleukin-6/antagonists & inhibitors/*biosynthesis MH - Kidney Tubules, Proximal/drug effects/*metabolism MH - Transcription Factor CHOP/antagonists & inhibitors/*biosynthesis EDAT- 2015/07/15 06:00 MHDA- 2016/02/13 06:00 CRDT- 2015/07/14 06:00 PHST- 2015/07/14 06:00 [entrez] PHST- 2015/07/15 06:00 [pubmed] PHST- 2016/02/13 06:00 [medline] AID - 9106 [pii] PST - ppublish SO - Eur Rev Med Pharmacol Sci. 2015 Jun;19(12):2303-10.